Trial Profile
Evaluation for antiatherogenic efficacy of febuxostat in patients with hyperuricemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Dec 2014
Price :
$35
*
At a glance
- Drugs Febuxostat (Primary)
- Indications Hyperuricaemia
- Focus Therapeutic Use
- 08 Dec 2014 Status changed from not yet recruiting to completed as reported by University Hospital Medical Information Network.
- 26 Nov 2012 New trial record